Live from the NIH registry
Studies recruiting near Oceanside right now
Top 25 of 706 recruiting studies, sorted by proximity — each links to its official registry page
Zenith® Fenestrated+ Clinical Study
Aortic Aneurysm, Abdominal, Juxtarenal Aortic Aneurysm
N/A
Interventional 105 participants sought
UC San Diego — La Jolla, California (26.2 mi)
· Sponsor: Cook Research Incorporated
Radicle GI Health DBG: A Study Assessing the Impact of Health and Wellness Products on GI Health and Related Health Outcomes
Belly Pain, GI Health
N/A
Interventional 825 participants sought
Radicle Science Inc. — Del Mar, California (18.5 mi)
· Sponsor: Radicle Science
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma
Phase 2
Interventional 188 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: National Cancer Institute (NCI)
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
Amyloidosis, Amyloid Cardiomyopathy
Phase 3
Interventional 587 participants sought
University of California, San Diego (UCSD) - Medical Center — La Jolla, California (26.2 mi)
· Sponsor: Eidos Therapeutics, a BridgeBio company
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Heart Transplant, Heart Failure
N/A
Interventional 60 participants sought
UC San Diego Health — La Jolla, California (26.2 mi)
· Sponsor: XVIVO Perfusion
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Relapsed Refractory Multiple Myeloma
Phase 3
Interventional 508 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
Efficacy of Fusidic Acid 1% in the Treatment of Bacterial Conjunctivitis
Bacterial Conjunctivitis
Phase 3
Interventional 400 participants sought
Baxis Site 19 — La Jolla, California (26.2 mi)
· Sponsor: Baxis Pharmaceuticals, Inc.
A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer)
Phase 1
Interventional 140 participants sought
UC San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: Nuvectis Pharma, Inc.
Women SHINE: Addressing Syndemics and HIV Among Women Through Tech-Based Peer Engagement
HIV/AIDS
N/A
Interventional 360 participants sought
The Regents of the Univ. of Calif., U.C. San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
Advanced/Metastatic Solid Tumors, Colorectal Cancer
Phase 1, Phase 2
Interventional 523 participants sought
UCSD — La Jolla, California (26.2 mi)
· Sponsor: Merus B.V.
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
Contraception, Pain, Acute
N/A
Interventional 204 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
Asthma
Phase 3
Interventional 231 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: AstraZeneca
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
Respiratory Distress Syndrome, Pre-term Infants
Phase 3
Interventional 520 participants sought
Jacobs Medical Center — La Jolla, California (26.2 mi)
· Sponsor: Aerogen Pharma Limited
MOTION Clinical Trial
Osteoarthritis, Knee
N/A
Interventional 100 participants sought
Scripps Clinic Jefferson — Oceanside, California (4.6 mi)
· Sponsor: Moximed
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Episodic Migraine
Phase 3
Interventional 450 participants sought
Excell Research, Inc /ID# 247532 — Oceanside, California (4.6 mi)
· Sponsor: AbbVie
Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 220 participants sought
UC San Diego Health — La Jolla, California (26.2 mi)
· Sponsor: Regeneron Pharmaceuticals
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Headlands Research — Escondido, California (14.8 mi)
· Sponsor: Zucara Therapeutics Inc.
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
Breast Neoplasms
Phase 3
Interventional 558 participants sought
University Of California - San Diego Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: BioNTech SE
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
Gastrointestinal Stromal Tumor (GIST), Gastrointestinal Stromal Cancer
Phase 1
Interventional 157 participants sought
University of California, San Diego — La Jolla, California (26.2 mi)
· Sponsor: Kura Oncology, Inc.
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
Cancer, Fertility Preservation
Phase 3
Interventional 2,800 participants sought
University of California San Diego — La Jolla, California (26.2 mi)
· Sponsor: University of California, San Diego
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Metastatic Clear Cell Renal Cell Carcinoma, Advanced Clear Cell Renal Cell Carcinoma
Phase 3
Interventional 720 participants sought
Research Site — La Jolla, California (26.2 mi)
· Sponsor: Arcus Biosciences, Inc.
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Ovarian Neoplasms, Endometrial Neoplasms
Phase 1
Interventional 495 participants sought
University of California, San Diego (UCSD) - Moores Cancer Center — La Jolla, California (26.2 mi)
· Sponsor: Eli Lilly and Company
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Carcinoma, Non-Small-Cell Lung
Phase 2
Interventional 130 participants sought
Moores Cancer Center at UC San Diego Health — La Jolla, California (26.2 mi)
· Sponsor: Johnson & Johnson Enterprise Innovation Inc.
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Non-Small Cell Lung Cancer, Colorectal Cancer
Phase 1
Interventional 113 participants sought
University of Southern California — La Jolla, California (26.2 mi)
· Sponsor: Fate Therapeutics
A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer
Prostatic Neoplasms, Castration-Resistant
Phase 3
Interventional 800 participants sought
University Of California San Diego — La Jolla, California (26.2 mi)
· Sponsor: Janssen Research & Development, LLC